<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaceutical-business-review.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aurobindo_obtains_final_approval_for_risperidone_oral_solution_090907-2/</loc>
		<lastmod>2009-09-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/speciality_european_pharma_launches_regurin_xl_in_uk_090907-2/</loc>
		<lastmod>2009-09-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meda_cipla_extend_collaboration_for_azelastine_fluticasone_combination_090907-2/</loc>
		<lastmod>2009-09-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/suven_receieves_milestone_payment_from_eli_lilly_090907-2/</loc>
		<lastmod>2009-09-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/canfite_reports_positive_results_of_phase_ii_trial_for_cf101_090907-2/</loc>
		<lastmod>2009-09-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_to_provide_ah1n1_vaccine_to_brazilian_government_090907-2/</loc>
		<lastmod>2009-09-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomerieux_raises_margin_target_with_increase_of_h1_090907-2/</loc>
		<lastmod>2009-09-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chugai_to_increase_supply_of_tamiflu_in_japan_090907-2/</loc>
		<lastmod>2009-09-07T05:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jordanian_stem_cell_company_acquires_stem_cell_technology_from_stemedica_090907-2/</loc>
		<lastmod>2009-09-07T05:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_to_launch_drugs_in_india_090907-2/</loc>
		<lastmod>2009-09-07T09:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen_debiopharm_sign_license_agreement_090907-2/</loc>
		<lastmod>2009-09-07T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dcgi_to_issue_who_compliance_certificates_in_india_090907-2/</loc>
		<lastmod>2009-09-07T12:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genego_licences_proteostasis_for_metacore_090908-2/</loc>
		<lastmod>2009-09-07T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/octoplus_bags_drug_delivery_evaluation_contract_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/opexa_reports_additional_analysis_of_phase_iib_terms_clinical_study_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xenoport_reports_preliminary_results_for_phase_2_arbaclofen_placarbil_trial_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protalix_wins_fdas_orphan_drug_designation_for_prgcd_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/geopharma_reports_settlement_of_litigation_with_cpg_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/repros_reports_financing_of__10m_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle_genetics_achieves_milestone_with_bayer_schering_pharma_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytrx_receives_letter_from_fda_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cell_biosciences_enters_agreement_to_acquire_alpha_innotech_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligocyte_initiates_third_human_clinical_trial_for_norovirus_vaccine_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeolus_initiates_study_of_aeol_10150_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ebioscience_acquires_natutec_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/coria_laboratories_provides_update_on_acanya_gel_study_for_acne_vulgaris_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osiris_therapeutics_declares_preliminary_results_for_prochymal_phase_iii_gvhd_trials_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine_pharmaceuticals_advances_in_bavituximab_clinical_program_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/albemarle_forms_strategic_alliance_with_meadwestvaco_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mwv_to_launch_medeasy_in_europe_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ista_reports_two_preliminary_results_of_tpred_studies_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_grants_marketing_approval_for_salixs_metozolv_odt_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_istas_bepreve_eye_drop_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/navitus_signs_contract_with_three_arizona_government_trusts_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/laureate_pharma_signs_manufacturing_agreement_with_neoprobe_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/caretech_signs_consent_decree_with_fda_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bhr_pharma_to_initiate_phase_3_synapse_study_for_progesterone_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galenica_acquires_om_pharma_to_expand_business_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto_publishes_stemedicas_patent_application_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer_acquires_prenatal_newborn_screening_laboratory_in_india_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rina_5_prime_take_over_roches_rts_proteinexpression_portfolio_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vical_receives_25m_payment_as_fund_from_anges_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_awards_grant_to_vaxart_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_awards_grant_to_dor_for_phase_12_trial_of_dor201_090908-2/</loc>
		<lastmod>2009-09-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb_selects_cambridge_semantics_anzo_suite_090908-2/</loc>
		<lastmod>2009-09-08T06:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/verichip_corporation_to_acquire_steel_vault_090908-2/</loc>
		<lastmod>2009-09-08T07:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pricespective_makes_new_appointments_090908-2/</loc>
		<lastmod>2009-09-08T10:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meda_introduces_edluar_for_insomnia_090908-2/</loc>
		<lastmod>2009-09-08T10:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/palatin_technologies_reports_revenues_of_114m_090908-2/</loc>
		<lastmod>2009-09-08T10:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_to_launch_three_drugs_in_india_090908-2/</loc>
		<lastmod>2009-09-08T11:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cipla_form_joint_venture_with_established_chinese_company_090908-2/</loc>
		<lastmod>2009-09-08T12:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sangamos_zinc_finger_nuclease_technology_used_to_efficiently_modify_human_stem_cells_090908-2/</loc>
		<lastmod>2009-09-08T12:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amarillo_biosciences_reports_results_for_phase_2_australian_clinical_study_of_interferon_090908-2/</loc>
		<lastmod>2009-09-08T12:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rosetta_genomics_and_axa_sign_distribution_agreement_in_italy_090908-2/</loc>
		<lastmod>2009-09-08T12:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_acquires_suzhou_taizhu_technology_development_co_090908-2/</loc>
		<lastmod>2009-09-08T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec_enters_into_research_agreement_with_biogen_idec_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/solvay_biologicals_completes_validation_for_its_cellbased_production_facility_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xoma_signs_antibody_discovery_collaboration_with_arana_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cempra_initiates_phase_23_clinical_study_for_cem102_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nephrogenex_completes_patient_enrollment_of_phase_2b_trial_for_pyridorin_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regado_reports_first_patient_enrollment_in_radar_phase_2b_study_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nuvilex_enters_into_joint_venture_agreement_with_legacy_biotechnologies_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/humco_increases_production_of_cherry_syrup_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/atyr_pharma_receives_us_patent_for_p43_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_awards_287m_grant_to_ceragenix_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oramed_pharmaceuticals_initiates_human_clinical_trials_for_an_oral_glp1_analog_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chemgenex_submits_nda_for_omapro_to_fda_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/almirall_to_file_maa_with_european_medicines_agency_for_eklira_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epo_issues_notification_of_intent_to_grant_patent_in_kreutzerlimmer_iii_patent_series_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/affymax_unveils_phase_3_program_update_hematide_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anadys_reports_first_patient_dosing_in_phase_ii_trial_for_ana598_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chelsea_completes_enrollment_for_phase_iii_trial_of_droxidopa_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/targeted_genetics_sells_manufacturing_assets_to_genzyme_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovista_reports_positive_efficacy_results_in_preclinical_trial_for_bva201_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cumberland_launches_caldolor_in_us_090909-2/</loc>
		<lastmod>2009-09-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mro_acquires_record_enterprises_090909-2/</loc>
		<lastmod>2009-09-09T06:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osi_systems_signs_partnership_agreement_for_ambulatory_blood_pressure_monitoring_software_090909-2/</loc>
		<lastmod>2009-09-09T06:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayers_breeze2_meter_available_in_new_colors_090909-2/</loc>
		<lastmod>2009-09-09T09:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_opens_new_cosmetic_technology_center_in_darmstadt_090909-2/</loc>
		<lastmod>2009-09-09T12:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synexus_opens_two_new_research_centres_in_pretoria_090909-2/</loc>
		<lastmod>2009-09-09T13:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/misonix_signs_new_sales_agency_agreement_for_middle_east_india_and_pakistan_090909-2/</loc>
		<lastmod>2009-09-09T13:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/socma_monitoring_development_of_green_chemistry_standard_090909-2/</loc>
		<lastmod>2009-09-09T14:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_removes_clinical_hold_on_dynavaxs_heplisav_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genscript_signs_biology_research_collaboration_with_roche_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytrx_receives_european_patent_for_arimoclomol_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_provides_update_on_its_investigational_cgrp_receptor_antagonists_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quintiles_forms_clinical_research_partnership_with_university_of_pretoria_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stemcells_to_begin_phase_i_clinical_trial_to_evaluate_hucnssc_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_grants_approval_for_generex_orallyn_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pluristem_initiates_enrollment_in_phase_i_clinical_trial_for_plxpad_in_us_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centocor_ortho_receives_fdas_complete_response_letter_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mpex_reports_positive_phase_2b_clinical_trial_results_for_aeroquin_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access_unveils_update_on_clinical_development_plan_for_prolindac_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scarab_neoclone_sign_license_agreement_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/law_offices_files_lawsuit_against_sepracor_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quatrx_reports_positive_results_from_second_phase_3_study_of_ophena_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/halozyme_reports_first_patient_dosing_in_phase_1_clinical_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/united_bio_source_acquires_cdr_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inviragen_obtains_additional_grant_from_nih_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ascenta_to_initiate_phase_1_clinical_trial_for_advanced_cancer_patients_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/par_pharmaceutical_receives_approval_for_nateglinide_tablets_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acceleron_unveils_preliminary_results_of_ace031_phase_1_trail_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tevas_copaxone_reduces_disease_severity_090910-2/</loc>
		<lastmod>2009-09-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schuylkill_health_selects_global_med_technologiess_transfusion_software_090910-2/</loc>
		<lastmod>2009-09-09T21:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acorda_therapeutics_reports_efficacy_safety_data_for_fampridinesr_extension_study_090910-2/</loc>
		<lastmod>2009-09-10T02:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vicals_influenza_vaccine_demonstrates_crossreactivity_against_h1n1_strains_090910-2/</loc>
		<lastmod>2009-09-10T02:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gatc_biotech_to_double_floor_space_at_constance_site_090910-2/</loc>
		<lastmod>2009-09-10T02:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/esperance_pharmaceuticals_initiates_clinical_studies_for_ep100_in_patients_with_cancer_090910-2/</loc>
		<lastmod>2009-09-10T02:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/map_pharmaceuticals_presents_phase_3_levadex_data_090910-2/</loc>
		<lastmod>2009-09-10T05:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos_initiates_second_phase_i_clinical_trial_for_glpg0259_090910-2/</loc>
		<lastmod>2009-09-10T06:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arpida_evolva_plan_merger_090910-2/</loc>
		<lastmod>2009-09-10T09:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/akzonobel_to_realign_company_portfolios_090910-2/</loc>
		<lastmod>2009-09-10T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_accepts_merzs_pma_application_for_belotero_balance_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_awards_phase_ii_sbir_grant_to_signum_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys_cymbalta_maintains_reduction_in_chronic_low_back_pain_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biocon_seals_development_commercialisation_agreement_with_amylin_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_millennium_initiate_phase_ii_trial_for_tak700_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/theravance_astellas_report_fda_approval_of_vibativ_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_regeneron_discontinue_phase_3_trial_for_aflibercept_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzymes_alemtuzumab_shows_durable_treatment_benefit_in_fouryear_phase_2_trial_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_reports_results_of_phase_ii_study_with_teriflunomide_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_reports_results_of_40week_improve_study_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_reports_new_data_from_clarity_phase_iii_trial_for_cladribine_tablets_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aobo_launches_yuyeqinghuo_capsules_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_gensperas_g202_for_phase_i_trial_for_cancer_treatment_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/levi__korsinsky_files_lawsuit_against_sepracor_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access_signs_agreement_with_accupac_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_clears_ova1_for_ovarian_cancer_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dsmb_recommends_continuation_of_delcaths_phase_iii_clinical_trial_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/agraquest_alpharma_animal_health_pair_up_for_supply_agreement_090911-2/</loc>
		<lastmod>2009-09-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest_presents_analysis_of_two_phase_iii_studies_of_ceftaroline_090912-2/</loc>
		<lastmod>2009-09-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vitro_study_of_adamas_tcad_shows_activity_against_drugresistant_influenza_viruses_090913-2/</loc>
		<lastmod>2009-09-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alcon_to_acquire_esbatech_090913-2/</loc>
		<lastmod>2009-09-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead_publishes_data_from_dar311_phase_iii_trial_090913-2/</loc>
		<lastmod>2009-09-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_evaluates_isentress_in_comparison_to_efavirenz_090913-2/</loc>
		<lastmod>2009-09-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tobira_provides_results_from_invitro_tbr652_study_090913-2/</loc>
		<lastmod>2009-09-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nektar_data_shows_nktr118_favorable_oral_bioavailability_drugdrug_interaction_profile_090913-2/</loc>
		<lastmod>2009-09-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_reports_tamiflu_increases_survival_in_avian_other_flu_090913-2/</loc>
		<lastmod>2009-09-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medassurant_take_over_catalyst_technologies_090914-2/</loc>
		<lastmod>2009-09-13T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/addex_adx10059_demonstrates_potential_for_parkinsons_disease_levodopainduced_dyskinesia_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/octoplus_signs_agreement_with_axentis_pharma_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kenta_provides_positive_phase_iia_results_for_panobacumab_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_accepts_mylans_anda_filing_for_generic_copaxone_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sfda_approves_abbotts_xience_v_drug_eluting_stent_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_obtains_european_approval_for_kaletra_tablet_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antisense_receives_orphan_drug_designation_from_fda_emea_for_trabedersen_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scheringplough_reveals_results_of_saphris_relapse_prevention_clinical_study_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aastroms_q4_revenues_decline_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inspire_to_expand_azasite_production_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dci_receives_complete_response_letter_for_pancrecarb_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mpex_reports_positive_results_from_phase_2b_clinical_trial_with_aeroquin_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tobira_reports_phase_i_pharmacokinetic_data_for_tbr652_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scheringplough_reports_vicriviroc_data_for_phase_ii_victore1_study_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protalix_concludes_pivotal_phase_iii_trial_for_uplyso_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_provide_results_from_first_clinical_trial_assessing_h1n1_adjuvanted_vaccine_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ribx_to_enter_into_clinical_trials_agreement_with_nih_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celldex_reports_first_patient_dosing_in_phase_12_clinical_trial_for_cdx1401_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron_completes_enrollment_in_two_phase_3_studies_for_wet_amd_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/artielle_provides_positive_results_for_phase_1_trial_of_rtl1000_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avi_biopharma_reports_effectiveness_of_immune_control_through_rnabased_therapeutics_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ariad_reports_result_phase_3_succeed_trial_data_of_oral_ridaforolimus_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeolus_pharmaceuticals_initiates_second_study_for_aeol_10150_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_provides_new_data_from_phase_iib_clinical_study_of_odanacatib_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiums_gene_activated_matrix_technology_accelerates_periodontal_tissue_regeneration_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orasi_medical_expands_to_tokyo_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytrx_cephalon_initiate_dose_escalation_study_for_treatment_of_apl_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vical_presents_data_of_phase_2_trial_for_transvax_cmv_vaccine_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elan_amends_terms_of_transaction_with_johnson__johnson_090914-2/</loc>
		<lastmod>2009-09-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/symyx_ties_up_with_safebiopharma_090915-2/</loc>
		<lastmod>2009-09-14T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/appeals_court_affirms_patent_infringement_rulings_against_roche_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ap_pharma_signs_agreement_with_merial_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_receives_expanded_license_for_isentress_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/poniards_phase_3_spear_trial_reaches_320_event_target_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pieris_enters_into_collaboration_agreement_with_allergan_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bavarian_nordic_signs_contract_to_deliver_imvamune_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_grants_orphan_drug_designation_to_advanced_life_sciences_restanza_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biocryst_signs_letters_of_intent_for_marketing_distribution_of_peramivir_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/huya_gibh_in_strategic_partnership_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nikem_receives_certification_for_glp_bioanalysis_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_for_pivotal_phase_iii_study_with_oncovex_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genova_gains_access_to_bridge_bioresearchs_distribution_channels_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basilea_provides_data_on_bal30072_against_multiresistant_gramnegative_bacteria_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cti_submits_pediatric_investigation_plan_to_emea_for_approval_of_pixantrone_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_provides_results_from_phase_iii_trial_of_qab149_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phosphagenics_completes_phase_1_study_of_oxycodone_transdermal_matrix_patch_system_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo_fisher_appoints_marc_casper_as_president_ceo_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lexicon_initiates_phase_2_clinical_trial_for_lx4211_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_provides_data_from_fiveyear_vertebral_fracture_prevention_study_with_bazedoxifene_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_licenses_sanofi_pasteurs_monovalent_vaccine_090915-2/</loc>
		<lastmod>2009-09-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genova_biotherapeutics_enters_collaboration_agreement_with_prime_bioresearch_090915-2/</loc>
		<lastmod>2009-09-15T12:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristolmyers_squibb_sales_otc_assets_to_taisho_pharmaceutical_090915-2/</loc>
		<lastmod>2009-09-15T12:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cepacol_introduces_cepacol_fizzlers_for_sore_throat_relief_090915-2/</loc>
		<lastmod>2009-09-15T12:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iflow_launches_full_line_of_onq_silverdressings_090915-2/</loc>
		<lastmod>2009-09-15T13:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lyondellbasell_to_close_ldpe_unit_at_carrington_uk_090915-2/</loc>
		<lastmod>2009-09-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clariant_to_open_new_production_facility_in_dayabay_china_090915-2/</loc>
		<lastmod>2009-09-15T13:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ppd_opens_global_central_lab_in_singapore_090915-2/</loc>
		<lastmod>2009-09-15T14:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/second_usegypt_collaborative_clinical_study_blocked_by_new_york_state_department_of_health_090915-2/</loc>
		<lastmod>2009-09-15T15:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/matrix_obtains_tentative_fda_approval_for_three_arv_products_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avaxia_biologics_receives_phase_i_sbir_grant_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmabcine_closes_6m_series_a_financing_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celsci_to_initiate_first_clinical_study_with_hospitalised_h1n1_infected_patients_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen_licenses_exclusive_right_to_use_immunogens_tap_technology_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/board_of_directors_approves_44m_expansion_for_hemispherxs_manufacturing_facilities_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qiagen_acquires_additional_licenses_from_roche_idaho_technology_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/coughlin_stoia_files_lawsuit_against_cardionet_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/keryx_receives_orphandrug_designation_for_perifosine_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_sirions_new_drug_application_for_zirgan_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_advisory_committee_recommends_approval_of_xiaflex_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oculus_signs_new_partnership_agreement_with_vm_industries_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_requires_boxed_warning_for_promethazine_hydrochloride_injection_090916-2/</loc>
		<lastmod>2009-09-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/progenics_makes_management_changes_090916-2/</loc>
		<lastmod>2009-09-16T09:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cell_therapeutics_reports_update_on_pixantrone_18_month_followup_trial_090916-2/</loc>
		<lastmod>2009-09-16T09:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanaria_receives_multiyear_nih_phase_ii_small_business_innovation_research_grant_090916-2/</loc>
		<lastmod>2009-09-16T10:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dnage_initiates_observational_study_in_children_suffering_from_cockayne_syndrome_090916-2/</loc>
		<lastmod>2009-09-16T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/soseis_qva149_phase_ii_data_presented_at_european_respiratory_society_annual_meeting_090916-2/</loc>
		<lastmod>2009-09-16T11:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pioneering_technology_will_detect_dna_damage_to_radiation_incident_victims_090916-2/</loc>
		<lastmod>2009-09-16T12:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/raindance_technologies_clc_bio_collaborate_to_develop_specialised_software_090917-2/</loc>
		<lastmod>2009-09-16T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/plan_b_onestep_emergency_contraception_available_in_us_090916-2/</loc>
		<lastmod>2009-09-16T13:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nuphysicia_creates_brazilbased_subsidiary_090916-2/</loc>
		<lastmod>2009-09-16T14:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/smith__nephew_launches_allevyn_range_extension_090916-2/</loc>
		<lastmod>2009-09-16T14:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_to_launch_40_sustainable_packaging_initiatives_090916-2/</loc>
		<lastmod>2009-09-16T14:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tianyin_receives_gmp_certification_from_sfda_090916-2/</loc>
		<lastmod>2009-09-16T14:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/linde_sets_up_regional_rd_centre_in_shanghai_090916-2/</loc>
		<lastmod>2009-09-16T14:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ranbaxy_inlicenses_cosmetic_product_for_indian_market_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_xenoport_reports_topline_results_for_phase_iib_pain_trial_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merial_licenses_scarab_genomics_clean_genome_e_coli_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regulus_alnylam_isis_reports_first_microrna_patent_grant_in_japan_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mds_appoints_steve_west_as_new_coo_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_novartis_valturna_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genova_signs_loi_agreement_with_korean_university_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rexahn_teva_agree_to_close_on_license_agreement_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intarcia_initiates_enrollment_of_itca_650_phase_2_diabetes_study_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bolder_receives_12m_nih_grant_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/juvaris_closes_first_series_b_financing_for_25m_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_aoxing_obtains_sfda_approval_for_cta_of_tilidinenaloxone_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym_biosciences_nimotuzumab_approved_for_marketing_in_mexico_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new_collaborative_research_program_to_help_advance_ppersonalized_medicine_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hyperion_wins_orphan_drug_designation_for_hpn100_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janseen_completes_acquisition_of_elans_alzheimers_immunotherapy_program_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/study_shows_memoryxl_improves_memory_cognitive_performance_in_alzheimers_disease_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pto_issues_notice_of_allowance_to_osi_pharmaceuticals_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gentium_q2_revenue_increases_despite_decline_in_h1_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schiff_nutrition_q1_sales_increases_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmacyclics_q4_net_loss_increases_090917-2/</loc>
		<lastmod>2009-09-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech_provides_positive_data_for_phase_iii_study_for_rituxan_090917-2/</loc>
		<lastmod>2009-09-17T05:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/app_pharmaceuticals_receives_approval_for_deferoxamine_mesylate_090917-2/</loc>
		<lastmod>2009-09-17T05:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/invitria_completes_beta_testing_of_optiferrin_for_mammalian_cell_culture_090917-2/</loc>
		<lastmod>2009-09-17T09:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotrove_selects_imagenes_as_openarray_service_provider_090917-2/</loc>
		<lastmod>2009-09-17T10:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wellcome_trust_merck_to_develop_affordable_vaccines_for_lowincome_countries_090917-2/</loc>
		<lastmod>2009-09-17T12:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/edifecs_launches_edifecs5010_comparison_manual_090918-2/</loc>
		<lastmod>2009-09-17T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wound_management_technologies_completes_acquisition_of__biopharma_management_technologies_090917-2/</loc>
		<lastmod>2009-09-17T13:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arkema_to_build_carbon_nanotube_pilot_plant_in_france_090917-2/</loc>
		<lastmod>2009-09-17T14:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ineos_nova_plans_to_close_ps_plant_at_netherlands_090917-2/</loc>
		<lastmod>2009-09-17T14:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dey_settles_state_of_utah_pricing_litigation_090917-2/</loc>
		<lastmod>2009-09-17T14:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teijins_biofronttm_demonstration_plant_begins_operation_090917-2/</loc>
		<lastmod>2009-09-17T14:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/california_stem_cell_stemina_biomarker_discovery_form_collaboration_090917-2/</loc>
		<lastmod>2009-09-17T15:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cloud_packaging_acquires_toll_packaging_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogaia_signs_distribution_agreement_with_laboratoires_bioethic_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_completes_acquisition_of_mercks_interest_in_merial_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/luna_innovations_receives_nasdaq_notification_for_bid_price_and_receives_grace_period_through_march_15_2010_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/health_discovery_appoints_john_a_norris_as_coo_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jennerex_completes_series_c_financing_for_56m_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_grants_priority_review_for_velcade_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zila_completes_merger_with_tolmar_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/resolvyx_gains_chronic_dry_eye_therapy_patent_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_ambrx_form_alliance_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boston_completes_enrollment_in_pivotal_workhorse_trial_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/newcardio_concludes_29m_private_placement_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cambridge_regulatory_services_signs_strategic_alliance_with_siro_clinpharm_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arena_reports_postiive_blossom_trial_results_for_weight_management_090918-2/</loc>
		<lastmod>2009-09-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/burkert_introduces_pneumaticcontrol_systems_090918-2/</loc>
		<lastmod>2009-09-18T08:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arena_pharmaceuticals_reports_positive_blossom_trial_results_090918-2/</loc>
		<lastmod>2009-09-18T15:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forestglenmark_reports_phase_iib_copd_study_results_090919-2/</loc>
		<lastmod>2009-09-19T11:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/praxair_china_bags_pharmaceutical_contract_090920-2/</loc>
		<lastmod>2009-09-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/assistmed_enters_into_agreement_with_kerr_health_care_services_090921-2/</loc>
		<lastmod>2009-09-20T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer_launches_columbus_20_platform_090921-2/</loc>
		<lastmod>2009-09-20T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant_provides_update_on_retigabine_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_signs_agreement_for_nektar_drug_development_programmes_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dor_biopharma_bags_94m_nih_grant_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/impax_pharmaceuticals_reports_results_phase_ii_parkinsons_trial_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/provectus_pharmaceuticals_completes_treatment_portion_of_phase_2_pv10_trial_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/enzo_biochem_enters_into_crada_with_national_eye_institute_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neuralstem_receives_fda_approval_to_initiate_phase_i_trial_for_als_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dsmb_recommends_continuation_of_celsions_phase_iii_thermodox_study_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/king_announces_commercial_availability_of_embeda_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/incyte_declares_positive_topline_phase_iib_results_for_topical_incb18424_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lorus_publishes_data_supporting_novel_mode_of_anticancer_therapy_for_lor253_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medimmune_receives_new_order_from_hhs_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dalton_expands_by_adding_formulation_development_090921-2/</loc>
		<lastmod>2009-09-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/varian_launches_new_productivity_suite_090921-2/</loc>
		<lastmod>2009-09-21T06:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glenmark_to_raise_inr12_billion_090921-2/</loc>
		<lastmod>2009-09-21T06:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsens_azzalure_approved_in_spain_for_aesthetic_use_090921-2/</loc>
		<lastmod>2009-09-21T06:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anavex_completes_scaleup_manufacturing_of_anavex_273_090921-2/</loc>
		<lastmod>2009-09-21T11:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen_presents_phase_3_trial_results_for_denosumab_090921-2/</loc>
		<lastmod>2009-09-21T11:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/impax_laboratories_confirms_patent_challenge_relating_to_oracea_090921-2/</loc>
		<lastmod>2009-09-21T11:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbotts_xience_v_outperforms_taxus_090921-2/</loc>
		<lastmod>2009-09-21T12:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icagen_extends_collaboration_with_pfizer_090921-2/</loc>
		<lastmod>2009-09-21T12:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/altos_oncology_metrics_plan_merger_090922-2/</loc>
		<lastmod>2009-09-21T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/concerro_launches_panfluaware_emergency_preparedness_solution_090922-2/</loc>
		<lastmod>2009-09-21T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nanoviricides_signs_master_service_agreement_with_southern_research_institute_090921-2/</loc>
		<lastmod>2009-09-21T13:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novostent_completes_enrollment_in_samba_femoropopliteal_trial_090921-2/</loc>
		<lastmod>2009-09-21T13:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeterna_zentaris_completes_phase_1_study_for_cancer_090921-2/</loc>
		<lastmod>2009-09-21T13:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sabril_now_available_in_us_090921-2/</loc>
		<lastmod>2009-09-21T14:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/karnataka_dc_urges_dcgi__to_amend_drugs__cosmetics_act_090921-2/</loc>
		<lastmod>2009-09-21T15:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer_ingelheim_enters_into_agreement_with_pfizer_to_acquire_assets_of_fort_dodge_animal_health_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iba_aposense_join_forces_to_commercialise_aposense_18fml10_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_receives_additional_order_for_h1n1_vaccine_from_us_government_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genomic_confirms_consistent_distribution_of_oncotype_dx_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actega_launches_solventfree_adhesives_based_on_renewable_raw_materials_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen_reveals_trail_results_for_metastatic_colorectal_cancer_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomarin_initiates_phase_2_clinical_study_of_pegpal_in_pku_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_posts_analysis_of_phase_ii_brain_study_for_avastin_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nktr102_demonstrates_antitumor_activity_in_ovarian_cancer_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sobran_ut_southwestern_medical_center_inks_multiyear_contract_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orbusneich_presents_positive_results_for_genous_bioengineered_r_stent_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ahf_to_open_blair_underwood_hivaids_clinic_in_dc_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qiagen_acquires_dxs_to_enhance_its_position_in_personalised_healthcare_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotime_to_organize_new_subsidiary_biotime_asia_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen_reports_phase_3_denosumab_versus_zometa_results_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nycomed_invests_in_new_pharmaceutical_production_plant_090922-2/</loc>
		<lastmod>2009-09-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/helsinns_palonosetron_effective_in_preventing_emesis_nausea_induced_by_high_dose_chemotherapy_090922-2/</loc>
		<lastmod>2009-09-22T10:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nutra_pharma_announces_plans_to_begin_drug_registration_process_in_canada_and_europe_090922-2/</loc>
		<lastmod>2009-09-22T12:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/datatrak_eclinical_supports_multifaceted_studies_090923-2/</loc>
		<lastmod>2009-09-22T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomagnetics_diagnostics_signs_distribution_agreement_with_bright_dairy_090922-2/</loc>
		<lastmod>2009-09-22T13:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/q_chip_to_develop_biopharmaceutical_portfolio_090922-2/</loc>
		<lastmod>2009-09-22T14:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vetter_plans_to_opens_technologically_advanced_service_facility_in_us_090922-2/</loc>
		<lastmod>2009-09-22T15:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gerresheimer_expands_rd_facility_in_us_090922-2/</loc>
		<lastmod>2009-09-22T15:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_provides_update_on_cerezyme_fabrazyme_supply_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead_sciences_attains_approval_for_conditional_marketing_authorisation_for_cayston_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emea_validates_pharmings_maa_for_rhucin_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_district_court_upholds_validity_of_lillys_evista_patents_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/federal_court_finds_edwards_lifesciences_patents_not_infringed_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gatc_biotech_expands_its_offerings_offers_human_genome_sequencing_services_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/invitria_launches_new_cell_culture_supplement_for_cho_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/frutarom_reveals_results_of_new_satiety_obesity_study_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/keryx_reports_results_for_zerenex_study_in_taiwan_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_onyx_present_results_of_nexavar_phase_ii_trial_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxygen_biotherapeutics_receives_approval_for_oxycyte_090923-2/</loc>
		<lastmod>2009-09-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssencilags_stelara__approved_by_nice_090923-2/</loc>
		<lastmod>2009-09-23T05:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zandu_pharma_plans_to_merger_with_emami_090923-2/</loc>
		<lastmod>2009-09-23T08:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/plexxikon_posts_encouraging_data_from_phase_1_extension_study_for_melanoma_090923-2/</loc>
		<lastmod>2009-09-23T09:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_seronos_erbitux_increases_survival_in_1stline_metastatic_colorectal_cancer_patients_090923-2/</loc>
		<lastmod>2009-09-23T10:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/take_solutions_inks_deal_with_novel_therapeutics_090923-2/</loc>
		<lastmod>2009-09-23T10:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cdsco_sets_up_new_office_in_karnataka_090923-2/</loc>
		<lastmod>2009-09-23T11:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/initial_coin_study_for_colorectal_cancer_fails_to_meet_primary_endpoint_090923-2/</loc>
		<lastmod>2009-09-23T11:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chongqing_jinshan_science__technology_ibm_pair_up_to_provide_medical_health_management_services_090924-2/</loc>
		<lastmod>2009-09-23T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_plans_expansion_in_india_090923-2/</loc>
		<lastmod>2009-09-23T13:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/india_still_in_hunt_for_h1n1_vaccine_090923-2/</loc>
		<lastmod>2009-09-23T13:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos_expands_contract_with_scheringplough_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xoma_to_develop_therapeutic_antibody_for_h1n1_h5n1_influenza_viruses_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbotts_xience_v_demonstrates_significantly_lower_rates_of_mace_stent_thrombosis_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thrombogenics_completes_enrollment_for_microplasmin_trial_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/combination_of_alvac_hiv_aidsvax_be_lowers_hiv_infection_by_312_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/richterhelm_biologics_completes_modernisation_of_production_facility_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_biologic_enters_into_research__development_agreement_with_ibt_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai_enters_into_agreement_with_pfizer_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osmetech_and_fisher_agree_to_terminate_us_distribution_agreement_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sandoz_completes_acquisition_of_ebewe_pharma_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arch_chemicals_appoints_three_members_to_senior_management_team_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_grants_priority_review_for_cephalons_nuvigil_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/laureate_enters_into_contract_with_zz_biotech_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/athera_biotechnologies_alpco_enter_into_agreement_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/enwave_declares_test_results_for_antibodies_using_freezerev_dehydration_technology_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hivaids_vaccine_trial_results_support_geovax_labs_strategy_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nycomed_to_invest_96m_for_russian_manufacturing_plant_090924-2/</loc>
		<lastmod>2009-09-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzymes_campath_meets_primary_endpoint_090924-2/</loc>
		<lastmod>2009-09-24T05:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hra_pharma_enters_into_marketing_distribution_agreement_with_acrux_090924-2/</loc>
		<lastmod>2009-09-24T06:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sartorius_stedim_biotech_to_launch_first_hic_membrane_adsorber_090924-2/</loc>
		<lastmod>2009-09-24T06:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck_reports_results_of_adagio_study_with_azilect_090924-2/</loc>
		<lastmod>2009-09-24T09:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen_posts_results_for_vectibix_in_combination_with_chemotherapy_090924-2/</loc>
		<lastmod>2009-09-24T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_pasteur_commends_results_of_first_hiv_vaccine_study_090924-2/</loc>
		<lastmod>2009-09-24T11:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/suitemeds_ehr_system_customized_to_receive_data_from_alr_technologies_healtheconnect_system_090925-2/</loc>
		<lastmod>2009-09-24T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/leo_pharma_repurchases_product_rights_from_warner_chilcott_090924-2/</loc>
		<lastmod>2009-09-24T13:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/health_canada_approves_glucagen_090924-2/</loc>
		<lastmod>2009-09-24T14:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dor_biopharma_announces_private_equity_financing_of_385m_090924-2/</loc>
		<lastmod>2009-09-24T14:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/morphotek_presents_farletuzumab_phase_ii_clinical_trial_data_090924-2/</loc>
		<lastmod>2009-09-24T15:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vical_presents_positive_preclinical_results_with_vaxfectinformulated_peptidebased_cancer_vaccine_090924-2/</loc>
		<lastmod>2009-09-24T15:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_launches_phase_3_clinical_trial_with_novel_alk_inhibitor_in_nsclc_090924-2/</loc>
		<lastmod>2009-09-24T16:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icagen_initiates_proofofconcept_study_for_ica105665_in_photosensitive_epilepsy_090924-2/</loc>
		<lastmod>2009-09-24T16:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/drugs_controller_general_of_india_lays_guidelines_for_copp_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nicox_submits_nda_for_naproxcinod_to_the_us_fda_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/active_biotechs_prostate_cancer_project_tasq_featured_in_british_journal_of_cancer_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas_brilinta_reduced_cardiovascular_deaths_heart_attacks_in_acs_patients_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aesica_receives_licence_to_manufacture_controlled_substances_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym_biosciences_reports_revenues_of_cad56_million_in_fiscal_2009_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/corgenix_reports_net_sales_of_81_million_in_fiscal_2009_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/repligen_reports_identification_of_drug_target_for_friedreichs_ataxia_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centocor_ortho_biotech_receives_fda_approval_for_stelara_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_receives_approval_for_qab149_for_patients_with_copd_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boston_scientific_reports_twoyear_followup_data_from_horizonsami_trial_090925-2/</loc>
		<lastmod>2009-09-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sp_consultants_vedant_enter_into_partnership_090925-2/</loc>
		<lastmod>2009-09-25T02:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioniche_pharma_launches_fomepizole_injection_090925-2/</loc>
		<lastmod>2009-09-25T05:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_allos_therapeutics_folotyn_090925-2/</loc>
		<lastmod>2009-09-25T06:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_focetria_receives_positive_opinion_from_chmp_090925-2/</loc>
		<lastmod>2009-09-25T06:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_receives_positive_chmp_opinion_for_januvia_janumet_090925-2/</loc>
		<lastmod>2009-09-25T08:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym_biosciences_revenues__of_56m_for_fy09_090925-2/</loc>
		<lastmod>2009-09-25T08:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/otc_drugs_hog_limelight_among_indian_consumers_090925-2/</loc>
		<lastmod>2009-09-25T11:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharma_giants_on_lookout_for_cure_against_no_frills_drugs_090925-2/</loc>
		<lastmod>2009-09-25T12:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/afc_sets_up_new_extraction_process_090925-2/</loc>
		<lastmod>2009-09-25T13:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_bids_for_solvay_090925-2/</loc>
		<lastmod>2009-09-25T14:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mexican_generic_company_buys_consigmas_continuous_granulation_drying_plant_090926-2/</loc>
		<lastmod>2009-09-26T12:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/onyx_initiates_phase_1_study_for_advanced_solid_tumors_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck__co_seals_agreement_with_csl_biotherapies_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/raptor_torreypines_receive_merger_approval_from_stockholders_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinochem_to_acquire_nufarm_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mitsubishi_chemical_ptt_sign_mou_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_pralatrexate_for_treatment_of_peripheral_tcell_lymphoma_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/addex_completes_enrollment_for_first_midstage_clinical_gerd_trial_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emea_committee_recommends_sanofiaventis_multaq_for_approval_in_european_union_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/afinitor_now_licensed_in_uk_for_advanced_kidney_cancer_after_firstline_treatment_failure_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_receives_positive_opinion_from_european_regulators_for_prevenar_13_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sensitel_releases_verisupply_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shengtai_posts_decrease_in_q4_despite_revenue_of_2410m_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nutricia_recalls_neocate_infant_product_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fss_receives_ide_approval_for_flexstent_femoropopliteal_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/probiotic_delivery_technology_awarded_patent_in_china_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inspirion_completes_preind_meeting_with_fda_090928-2/</loc>
		<lastmod>2009-09-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elsevier_launches_scival_funding_solution_090928-2/</loc>
		<lastmod>2009-09-28T04:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_to_acquire_solvay_pharmaceuticals_business_090928-2/</loc>
		<lastmod>2009-09-28T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb_astrazeneca_form_alliance_090928-2/</loc>
		<lastmod>2009-09-28T09:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson__johnson_crucell_enter_into_strategic_collaboration_090928-2/</loc>
		<lastmod>2009-09-28T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/plex_online_launches_erp_software_at_14_inteva_locations_090929-2/</loc>
		<lastmod>2009-09-28T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lonza_patheon_agree_to_extend_exclusivity_due_diligence_period_090928-2/</loc>
		<lastmod>2009-09-28T13:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pooled_clinical_data_analysis_shows_januvia_lowers_blood_sugar_levels_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/repros_therapeutics_provides_update_on_proellex_090929/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/camlin_fine_chemicals_not_to_divest_api_stakes_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alimera_reports_safety_efficacy_results_for_human_pk_iluvien_study_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scarab_genomics_introduces_scarabxpress_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/keryx_updates_single_agent_phase_2_data_of_krx0401_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_initiates_dosing_in_phase_1b_mad_study_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dynavax_initiates_phase_3_registration_trial_for_hepatitis_b_vaccine_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seracare_bags_multiple_contracts_from_cdc_nih_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hoviones_api_manufacturing_plant_passes_fda_inspection_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cordis_enters_into_agreement_with_boston_scientific_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boston_settles_patent_disputes_with_johnson__johnson_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotech_medics_enters_into_distribution_agreement_in_dubai_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imthera_medical_gets_ethics_committee_clearance_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/afresa_provides_rapid_suppression_of_endogenous_glucose_production_in_diabetics_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/polymedix_initiates_dosing_in_phase_1b_clinical_study_for_pmx60056_090929-2/</loc>
		<lastmod>2009-09-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cell_therapeutics_applies_for_european_orphan_drug_designation_090929-2/</loc>
		<lastmod>2009-09-29T05:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icagen_initiates_proofofmechanism_study_for_pain_090929-2/</loc>
		<lastmod>2009-09-29T06:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson_pharmaceuticals_reports_results_for_phase_i_study_for_gelnique_090929-2/</loc>
		<lastmod>2009-09-29T07:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_patent_office_to_reexamine_cellectis_patents_involved_in_litigation_090929-2/</loc>
		<lastmod>2009-09-29T09:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actavis_launches_topiramate_in_four_european_markets_090929-2/</loc>
		<lastmod>2009-09-29T11:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hanford_pharmaceuticals_reports_new_production_capabilities_090929-2/</loc>
		<lastmod>2009-09-29T11:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/skinvisible_enters_into_license_agreement_with_mayquest_pharma_for_dermsafe_090929-2/</loc>
		<lastmod>2009-09-29T12:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/omnicomm_systems_kendle_enter_into_multiyear_enterprise_agreement_090930-2/</loc>
		<lastmod>2009-09-29T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/selcia_launches_new_discovery_division_unveil_company_rebrand_090929-2/</loc>
		<lastmod>2009-09-29T13:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lupin_acquires_us_rights_for_antara_090929-2/</loc>
		<lastmod>2009-09-29T13:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/waste_reduction_increases_demand_for_sephas_pressout_deblistering_technologies_090929-2/</loc>
		<lastmod>2009-09-29T14:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/atmi_introduces_new_antistatic_film_090929-2/</loc>
		<lastmod>2009-09-29T14:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/palatin_to_receive_5m_from_astrazeneca_090929-2/</loc>
		<lastmod>2009-09-29T14:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nras_statement_on_tocilizumab_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alpharx_riso_pharma_sign_collaboration_licensing_agreement_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hospira_acquires_rights_to_biogeneric_version_of_filgrastim_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_submits_nda_for_cladribine_tablets_in_us_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_initiates_phase_ii_study_in_ra_patients_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biocryst_provides_updates_on_peramivir_for_influenza_patients_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sagent_launches_vinorelbine_injection_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hana_biosciences_enters_into_agreement_with_national_cancer_institute_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/welichem_files_phase_ii_trial_application_for_wbi1001_with_health_canada_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clikstar_gets_approval_in_eu_canada_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/canfite_initiates_preparatory_work_for_psoriasis_phase_iii_trial_090930-2/</loc>
		<lastmod>2009-09-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/caraco_pharmaceutical_laboratories_enters_into_consent_decree_with_fda_090930-2/</loc>
		<lastmod>2009-09-30T05:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hpv_vaccine_batch_recalled_while_investigation_underway_090930-2/</loc>
		<lastmod>2009-09-30T07:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nexavar_plus_paclitaxel_show_progression_free_survival_by_74_090930-2/</loc>
		<lastmod>2009-09-30T07:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_reports_twoyear_phase_iii_study_for_oral_ms_therapy_090930-2/</loc>
		<lastmod>2009-09-30T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_presents_results_for_headtohead_study_of_lantus_090930-2/</loc>
		<lastmod>2009-09-30T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_receives_approval_from_accc_for_pending_acquisition_of_wyeth_090930-2/</loc>
		<lastmod>2009-09-30T11:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sosei_files_nda_for_norlevo_in_japan_090930-2/</loc>
		<lastmod>2009-09-30T11:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cord_blood_america_opens_las_vegas_cryogenic_laboratory_090930-2/</loc>
		<lastmod>2009-09-30T11:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aphios_receives_nih_arra_challenge_grant_090930-2/</loc>
		<lastmod>2009-09-30T12:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/talyst_partners_rxinnovate_for_automation_implementation_091001-2/</loc>
		<lastmod>2009-09-30T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gedeon_richter_adopts_phase_forwards_clintrial_091001-2/</loc>
		<lastmod>2009-09-30T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan_receives_fda_approval_for_carbidopa_levodopa_090930-2/</loc>
		<lastmod>2009-09-30T13:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vibativ_gets_approval_from_health_canada_091001-2/</loc>
		<lastmod>2009-09-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hra_pharma_launches_ellaone_in_europe_091001-2/</loc>
		<lastmod>2009-09-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/provectus_initiates_phase_1_trial_for_liver_cancer_091001-2/</loc>
		<lastmod>2009-09-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/misonix_reports_net_sales_of_398_million_in_fiscal_2009_091001-2/</loc>
		<lastmod>2009-09-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto_allows_claims_covering_approved_administration_of_kuvan_with_food_091001-2/</loc>
		<lastmod>2009-10-01T05:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advaxis_provides_updated_phase_i_survival_data_for_cancer_vaccine_091001-2/</loc>
		<lastmod>2009-10-01T05:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/onset_therapeutics_launches_benzefoam_emollient_foam_091001-2/</loc>
		<lastmod>2009-10-01T06:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/opaxio_produces_high_rates_of_pathologic_complete_remission_in_patients_with_advanced_esophageal_cancer_091001-2/</loc>
		<lastmod>2009-10-01T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_merrimack_enter_into_global_collaboration_licensing_agreement_091001-2/</loc>
		<lastmod>2009-10-01T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sciele_pharma_addrenex_submit_snda_to_fda_for_clonicel_091001-2/</loc>
		<lastmod>2009-10-01T08:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_to_expand_operations_in_mexico_turkey_europe_091001-2/</loc>
		<lastmod>2009-10-01T11:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/caleco_pharma_signs_letter_of_intent_with_caleco_pharma_europe_091001-2/</loc>
		<lastmod>2009-10-01T11:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_posts_data_for_sandostatin_lar_depot_091001-2/</loc>
		<lastmod>2009-10-01T12:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/invivo_cevec_pharmaceuticals_sign_license_agreement_091001-2/</loc>
		<lastmod>2009-10-01T13:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kinaxo_launches_kinaffinity_services_091001-2/</loc>
		<lastmod>2009-10-01T14:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actavis_launch_atorvastatin_in_spain_091001-2/</loc>
		<lastmod>2009-10-01T14:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dow_sells_of_morton_for_1675_billion_091002-2/</loc>
		<lastmod>2009-10-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sciclone_discontinues_phase_2_trial_for_rp101_091002-2/</loc>
		<lastmod>2009-10-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amicus_reports_preliminary_results_from_phase_2_study_of_plicera_091002-2/</loc>
		<lastmod>2009-10-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allergan_files_federal_lawsuit_for_common_therapeutic_offlabel_treatments_of_botox_091002-2/</loc>
		<lastmod>2009-10-02T05:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perceptum_introduces_new_situational_leadership_v_series_091002-2/</loc>
		<lastmod>2009-10-02T05:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/india_to_finally_receive_swine_flu_drugs_091002-2/</loc>
		<lastmod>2009-10-02T07:43:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_pasteur_reported_results_of_us_clinical_trials_for_influenza_a_h1n1_vaccine_091002-2/</loc>
		<lastmod>2009-10-02T07:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_receives_h1n1_vaccines_from_novartis_091002-2/</loc>
		<lastmod>2009-10-02T08:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristolmyers_squibb_astrazeneca_report_results_for_phase_3_dapagliflozin_study_091002-2/</loc>
		<lastmod>2009-10-02T09:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_receives_emea_positive_opinion_for_celvapan_h1n1_vaccine_091002-2/</loc>
		<lastmod>2009-10-02T10:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anavex_selects_forenap_pharma_for_clinical_trials_of_anavex_273_091002-2/</loc>
		<lastmod>2009-10-02T11:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abacus_parenterals_drugs_opens_factory_in_uganda_091002-2/</loc>
		<lastmod>2009-10-02T11:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advanced_liquid_logic_gets_52_million_nih_contract_for_hiv_diagnostics_091002-2/</loc>
		<lastmod>2009-10-02T14:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech_reports_data_from_lucentis_phase_iii_studies_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inovio_reports_immunogenicity_data_from_cervical_cancer_vaccine_trial_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nutra_pharma_completes_first_production_run_of_cobroxin_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/santhera_completes_juvantia_acquisition_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer_therapeutics_collaborates_with_duke_university_to_develop_cancer_drugs_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kureha_signs_licensing_agreement_with_mitsubishi_tanabe_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diagnocure_to_launch_previstage_gcc_colorectal_cancer_staging_test_in_uk_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medigenes_receives_uk_mhra_feedback_on_rhudex_clinical_development_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/theraclone_signs_multiyear_rd_agreement_with_zenyaku_kogyo_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle_genetics_discontinues_dacetuzumab_phase_iib_clinical_trial_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sigmaaldrich_sangamo_extend_license_agreement_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biochemics_collaborates_with_unilever_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_xenoport_unveil_gabapentin_enacarbil_phase_ii_trial_results_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european_commission_grants_marketing_authorisation_for_onglyza_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo_fisher_to_close_medical_device_production_facility_in_nashua_new_hampshire_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_obtains_unanimous_fda_panel_approval_recommendation_for_votrient_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_unveils_study_results_on_adults_with_inadequate_glycemic_control_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sri_international_bags_new_contract_from_nimh_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thrombogenics_reveals_results_of_diabetic_macular_edema_trial_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytopia_to_merge_with_ym_biosciences_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine_reports_positive_results_of_bavituximab_trial_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inviragen_merges_with_singvax_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lupin_grants_us_rights_for_bioadhesive_technology_for_rifaximin_to_salix_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/coldpack_to_unveil_new_pharmaceutical_pouch_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_oncologic_drug_advisory_committee_recommends_enzons_pegintron_for_approval_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/depomed_reports_positive_topline_results_from_phase_3_trial_of_dm1796_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cellix_signs_distribution_agreement_with_chromaphor_091005-2/</loc>
		<lastmod>2009-10-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/patheon_signs_agreement_with_zycus_091006-2/</loc>
		<lastmod>2009-10-05T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/illumina_launches_integrated_computing_for_genome_analyzer_sequencing_platform_091006-2/</loc>
		<lastmod>2009-10-05T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sandoz_launches_somatropin_in_japan_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_accepts_abstral_nda_filing_for_review_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avita_medical_gets_japanese_patent_for_improved_drug_delivery_device_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_unveils_update_on_government_orders_for_h1n1_vaccine_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncogenex_receives_additional_fast_track_designation_from_fda_for_ogx011_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_forms_jv_with_chinese_biotech_firm_for_paediatric_vaccines_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rtech_ueno_initiates_early_phase_ii_clinical_trial_for_rk023_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_selects_wyatt_technologys_dawn_heleos_mals_instrument_for_drug_discovery_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biodelivery_sciences_obtains_13m_grant_from_us_army_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acadia_provides_update_on_phase_iii_program_with_pimavanserin_for_pdp_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/topica_reveals_phase_2_results_of_luliconazole_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imedicor_enters_into_agreement_with_access_pharmaceuticals_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioreliance_launches_validated_assay_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/md_biosciences_launches_new_product_division_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xenomics_appoints_bruce_a_huebner_as_ceo_and_board_member_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merz_reports_phase_iii_data_for_nt_201_trial_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boston_scientific_gets_fda_clearance_for_wallflex_biliary_rx_stents_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ground_zero_pharma_opens_new_office_in_brisbane_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centocor_orthos_simponi_gets_european_commission_approval_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perrigo_receives_final_approval_from_fda_for_polyethylene_glycol_3350_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pds_completes_glp_toxicology_studies_of_hpv_cancer_product_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/enzon_receives_european_commission_approval_for_cimzia_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vantia_enters_phase_ii_proofofconcept_trials_for_va111913_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/particle_sciences_dow_corning_pair_up_to_develop_new_product_technology_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cryocell_provides_update_on_breast_cancer_research_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_receives_fdas_complete_response_letter_for_clolar_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transdel_reports_positive_phase_3_results_for_ketotransdel_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/helix_provides_update_on_topical_interferon_alpha2b_ldos47_programs_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genprobe_to_acquire_prodesse_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_completes_shipment_of_fluvirin_to_us_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb_receives_ec_approval_for_cimzia_in_combination_with_mtx_091006-2/</loc>
		<lastmod>2009-10-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/geospizas_software_systems_receives_sbir_grant_for_detecting_rare_mutations_091007-2/</loc>
		<lastmod>2009-10-06T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas_boehringer_ingelheim_reach_settlement_with_impax_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos_reaches_first_milestone_in_antiinfectives_alliance_with_gsk_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diamyd_to_reach_milestone_in_phase_iii_program_for_diabetes_vaccine_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire_releases_data_from_headtohead_crossover_study_for_fosrenol_sevelamer_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/delsitech_forms_research_collaboration_with_orion_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_gets_marketing_authorisation_for_celvapan_h1n1_vaccine_from_european_commission_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/entest_applies_for_exploratorydevelopment_phase_ii_grant_from_nci_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/odyssey_to_receive_milestone_payments_from_pfizer_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/angelini_resolves_manufacturing_issue_with_fda_regarding_trazodone_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/relypsa_begins_phase_2b_clinical_trial_for_rly5016_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amarillo_biosciences_seals_agreement_with_intas_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zelos_initiates_patient_dosing_in_zt034_clinical_trial_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/idera_begins_phase_i_clinical_trial_for_imo2125_with_ribavirin_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avanir_receives_notice_of_allowance_for_zenvia_patient_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cipher_initiates_patient_enrollment_in_cipisotretinoin_phase_iii_study_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeoluss_aeol_10150_to_protect_lungs_from_whole_mustard_gas_exposure_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kylin_obtains_notice_of_allowance_on_us_patent_for_prna_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_daiichi_sankyos_snda_for_welchol_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vicals_transvax_cmv_vaccine_shows_positive_result_in_ongoing_phase_2_trial_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nutra_pharma_plans_to_launch_nyloxin_rx_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3m_drug_delivery_expands_operations_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biostar_receives_clearance_from_chinese_military_drug_administration_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/impax_settles_pending_litigation_for_flomax_capsules_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mannatech_secures_second_injunction_to_protect_glyconutrient_products_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanvita_cbgm_completes_acquisition_of_assets_of_ccs_medicals_subsidiary_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quest_diagnostics_performs_dna_testing_for_gene_variants_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synexus_to_initiates_cancer_vaccine_trials_091007-2/</loc>
		<lastmod>2009-10-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medical_connections_finalises_implementation_integration_of_erp_software_system_091008-2/</loc>
		<lastmod>2009-10-07T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pacific_biosciences_receives_grant_from_nih_091008-2/</loc>
		<lastmod>2009-10-07T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/app_obtains_fda_approval_for_sumatriptan_succinate_injection_usp_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_signs_agreement_with_paratek_for_ptk_0796_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen_spirogen_sign_new_agreement_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antisoma_plans_to_amend_accede_phase_iii_study_for_as1413_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/macuclear_mystic_unveil_preliminary_results_of_amd_trial_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_schering_partners_ac_immune_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogaia_seals_agreement_with_pharma_nord_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/labopharm_signs_agreement_with_grunenthal_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hospira_collaborates_with_celltrion_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nextpharma_begins_clinical_trial_services_in_us_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiopharmas_cardiapill_proceeds_for_fda_submission_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ims_health_sees_global_pharma_growth_at_46_in_2010_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arch_chemicals_enters_into_trade_accounts_receivable_securitisation_facility_with_pnc_bank_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_advisory_committee_recommends_approval_for_pfizers_selzentry_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_reaches_agreement_with_uspto_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medtronic_launches_captivia_delivery_system_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/edwards_lifesciences_to_develop_new_manufacturing_faciltiy_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/keryx_initiates_phase_2_clinical_study_for_krx0401_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/radient_grifols_enter_into_marketing_distribution_agreement_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lpath_reports_positive_results_of_phase_1_clinical_trial_for_isonep_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_pasteur_reports_positive_results_for_panenza_humenza_clinical_trials_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/plexxikon_initiates_dosing_in_phase_1_trial_for_plx3397_091008-2/</loc>
		<lastmod>2009-10-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/purdue_pharma_meets_fda_for_new_coating_of_oxycontin_091008-2/</loc>
		<lastmod>2009-10-08T15:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cornerstone_strengthens_its_scientific_advisory_board_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen_seals_collaboration_agreement_with_braintree_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stem_cell_therapy_receives_us_patent_for_stem_cells_isolation_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actelion_achieves_clinical_milestone_in_roche_alliance_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vivante_concludes_process_optimisation_contract_for_oxford_university_malaria_vaccine_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spectrum_obtains_fdas_complete_response_letter_for_fusilev_snda_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pieris_provides_update_on_prs050_program_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medigene_completes_patient_enrollment_in_phase_ii_trial_for_endotag1_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/locus_forms_research_collaboration_with_novartis_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_csl_behrings_berinert_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_reviews_fibrocells_azfibrocelt_for_wrinkles_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lid_hair_studios_completes_reverse_merger_with_shaanxi_jiali_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/blue_marble_energy_enters_into_partnership_with_bionavitas_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avanir_reveals_results_of_phase_iii_star_trial_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kba_increases_venture_capital_investment_in_kansas_bioscience_businesses_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomet_q1_net_sales_increases_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intralytix_bags_us_army_contract_to_develop_phagebased_probiotic_091009-2/</loc>
		<lastmod>2009-10-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kimberlyclark_signs_definitive_agreement_to_acquire_iflow_091009-2/</loc>
		<lastmod>2009-10-09T09:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioscience_laboratories_collaborates_with_synomics_091010-2/</loc>
		<lastmod>2009-10-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alife_launches_new_reconciliation_solution_for_healthcare_industry_091012-2/</loc>
		<lastmod>2009-10-11T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tcgrx_enters_into_strategic_partnership_with_netrx_091012-2/</loc>
		<lastmod>2009-10-11T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gobalto_launches_new_webbased_solution_091012-2/</loc>
		<lastmod>2009-10-11T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prolifiq_partners_ethicspoint_091012-2/</loc>
		<lastmod>2009-10-11T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/virtualhealth_technologies_enters_into_agreement_with_wound_care_innovations_091012-2/</loc>
		<lastmod>2009-10-11T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioalliance_receives_french_approval_for_fentanyl_lauriad_clinical_trial_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sun_pharma_gets_approval_to_launch_two_generics_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arch_pharmalabs_partners_orochem_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/santarus_seals_license_agreemet_with_norgine_for_zegerid_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heptares_signs_agreement_with_novartis_option_fund_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/onyx_all_set_to_acquire_proteolix_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merial_starts_expansion_project_in_nanchang_china_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/crescendo_raises_gbp45m_for_development_of_antibody_technology_platforms_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/raptor_reports_positive_results_from_phase_2a_trial_for_dr_cysteamine_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_to_unveil_parteck_odt_in_spain_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/depomed_provides_results_from_two_phase_3_breeze_clinical_trials_for_serada_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/noxxon_completes_first_phase_i_trial_for_spiegelmer_noxe36_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sohm_obtains_generic_pharmaceutical_orders_from_indian_distributors_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orion_genomics_signs_multiyear_collaboration_license_agreement_with_novartis_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celator_completes_enrollment_for_cpx351_trial_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mdrna_reports_progress_in_oncology_program_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immuneregen_begins_homspera_studies_for_swine_flu_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sequella_receives_twoyear_sbir_grant_from_nih_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qrxpharma_signs_contractual_agreement_with_patheon_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_unveils_final_results_from_fouryear_combat_study_for_bph_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ablynx_domantis_settle_dispute_enters_into_new_agreement_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phyton_buys_assets_of_natural_pharmaceuticals_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phyton_to_get_european_patent_for_taxane_production_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/physionetics_gets_national_institutes_of_health_grant_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dara_america_stem_cell_broaden_collaboration_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kaiser_permanente_ucsf_get_25m_grant_for_genetic_epidemiology_research_091012-2/</loc>
		<lastmod>2009-10-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basf_dow_support_new_patent_asset_index_091012-2/</loc>
		<lastmod>2009-10-12T06:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/czura_thornton_to_acquire_gcl_business_of_mds_pharma_services_091012-2/</loc>
		<lastmod>2009-10-12T08:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_suspends_patient_enrollment_in_latestage_cancer_drug_trial_091012-2/</loc>
		<lastmod>2009-10-12T09:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinclair_acquires_flammazine_flammacerium_from_solvay_091012-2/</loc>
		<lastmod>2009-10-12T12:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/msdc_to_test_potential_treatment_for_alzheimers_091012-2/</loc>
		<lastmod>2009-10-12T12:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_awards_more_than_54_million_to_kaiser_permanente_to_conduct_health_research_091012-2/</loc>
		<lastmod>2009-10-12T12:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new_research_leads_to_develop_a_high_tech_medical_tool_091012-2/</loc>
		<lastmod>2009-10-12T12:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/simulations_plus_launches_new_version_of_classpharmer_software_091013-2/</loc>
		<lastmod>2009-10-12T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/saltigo_unveils_custom_synthesis_services_for_apis_091012-2/</loc>
		<lastmod>2009-10-12T13:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_takes_over_bangalore_genei_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amt_obtains_orphan_drug_designation_from_ema_for_amt080_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/safc_pharma_completes_contract_manufacturing_facility_expansion_in_california_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antisomas_as1411_gets_orphan_drug_status_in_us_eu_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen_debiopharm_complete_european_decentralised_procedure_for_decapeptyl_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alkermes_reports_positive_topline_results_from_two_clinical_trials_for_alks_33_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nobilon_initiates_proof_of_concept_trial_for_sch_900795_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac_gets_approval_to_distribute_panflu_vaccine_in_hong_kong_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dyax_unveils_new_developments_related_to_phage_display_technology_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/compugen_collaborates_with_bayer_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lifeline_cell_technology_launches_new_products_into_human_cell_research_market_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/metabolex_reports_positive_phase_1_clinical_trial_results_of_mbx2982_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perrigo_files_anda_for_mens_rogaine_foam_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mwv_healthcare_completes_industrialisation_of_pfp_n_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/va_selects_aquilent_for_27m_health_it_support_contracts_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/applied_biosystems_announces_new_generation_of_forensic_dna_kits_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/champions_receives_us_patent_for_tubulin_sg410_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/opko_health_signs_agreement_with_scheringplough_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icon_strengthens_its_bioanalytical_sciences_group_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_collaborates_with_uk_government_wellcome_trust_eeda_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/freeman_technology_provides_new_insights_to_clarochem_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_warns_against_marketing_of_unapproved_codeine_sulfate_tablets_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire_sandoz_settle_adhd_patent_suits_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/provectus_completes_patient_accrual_in_phase_2_trial_of_ph10_for_psoriasis_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uip_passes_preapproval_inspection_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_grants_93m_to_nanobio_university_of_michigan_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/caleco_to_initiate_clinical_studies_for_lamiridosin_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medicis_gets_notice_of_allowance_from_uspto_for_solodyn_patent_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dow_to_introduce_a_new_variety_of_carbowax_sentry_polyethylene_glycol_091013-2/</loc>
		<lastmod>2009-10-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novavax_receives_sbir_grant_from_nih_091013-2/</loc>
		<lastmod>2009-10-13T05:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_enters_into_agreement_with_vanda_091013-2/</loc>
		<lastmod>2009-10-13T06:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gea_courtoy_adds_to_performa_range_091013-2/</loc>
		<lastmod>2009-10-13T07:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glaxosmithkline_prosensa_form_alliance_against_dmd_091013-2/</loc>
		<lastmod>2009-10-13T12:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/myriad_identifies_ind_candidate_for_treatment_of_cancer_obesity_diabetes_091013-2/</loc>
		<lastmod>2009-10-13T12:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basilea_receives_marketing_authorization_for_toctino_in_switzerland_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos_expands_strategic_alliance_with_merck_affiliate_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sosei_seals_agreement_with_biocopea_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dainippon_sumitomo_sepracor_completes_aptioms_tender_offer_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer_ingelheim_receives_marketing_authorisation_from_european_commission_for_mirapexinsifrol_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytheris_initiates_phase_iiia_clinical_trial_for_interleukin7_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/critical_pharmaceuticals_secures_gbp15m_from_wellcome_trust_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotech_medics_receives_independent_clinical_results_of_shban_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_gets_clearance_from_us_ftc_ccb_for_wyeth_acquisition_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli_lilly_to_sell_tippecanoe_to_evonik_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/affymetrix_partners_with_rpgeh_ucsf_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson__johnson_q3_sales_narrows_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomatrix_retains_private_grant_rd_firm_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nymox_reports_positive_results_for_nx1207_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/serametrix_partners_licr_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ortho_gets_fda_clearance_for_antihiv_12_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mindray_medical_to_exhibit_new_products_at_62nd_cmef_in_china_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/generex_orallyn_receives_fda_price_approval_under_treatment_ind_program_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/psividas_phase_iii_iluvien_trials_last_patient_completes_twoyear_followup_visit_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fero_to_acquire_pyro_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emea_providess_orphan_drug_status_to_arqules_arq_197_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zystor_receives_fda_clearance_for_zc701_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_reports_365_surge_in_q3_earnings_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_pasteur_reports_results_of_clinical_trials_of_influenza_a_vaccine_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ziopharm_reports_positive_phase_ii_interim_data_for_palifosfamide_091014-2/</loc>
		<lastmod>2009-10-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/suven_life_gets_patent_rights_for_suvn502_091014-2/</loc>
		<lastmod>2009-10-14T08:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_settles_drug_dispute_with_mylan_on_vfend_091014-2/</loc>
		<lastmod>2009-10-14T09:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/illumina_countersues_life_technologies_for_patent_infringement_091014-2/</loc>
		<lastmod>2009-10-14T12:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iroko_selects_bottomline_for_global_transactional_document_initiative_091015-2/</loc>
		<lastmod>2009-10-14T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transposagen_expands_licence_for_piggybac_technology_091015-2/</loc>
		<lastmod>2009-10-14T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_seals_agreement_with_dyesol_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/graffinity_signs_drug_discovery_research_collaboration_with_genentech_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec_extends_research_collaboration_with_ono_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan_obtains_fda_approval_for_topiramate_capsules_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivir_gets_approval_for_its_marketing_authorisation_in_europe_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/radient_enters_into_research_collaboration_agreement_with_cetecancer_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_reports_net_income_of_530_million_in_q3_2009_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eyegate_concludes_phase_ii_study_for_egp437_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inovio_initiates_phase_i_clinical_trial_for_pennvaxb_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lhc_enters_into_definitive_agreement_with_feliciana_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_acquires_wyeth_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prometheus_launches_three_new_proonc_cancer_diagnostics_products_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celsion_receives_sfda_approval_for_global_phase_iii_thermodox_trial_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tyrian_seeks_new_partner_opportunities_for_tuberculosis_diagnostic_tests_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/health_decisions_builds_international_cro_community_on_agile_clinical_development_methodology_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/threshold_seals_license_agreement_with_eleison_091015-2/</loc>
		<lastmod>2009-10-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kinaxo_biotechnologies_bayer_vital_collaborate_in_phosphoproteomics_biomarker_identification_091015-2/</loc>
		<lastmod>2009-10-15T02:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basf_expands_epoxy_resin_systems_lab_091015-2/</loc>
		<lastmod>2009-10-15T04:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pikamab_secures_critical_patent_rights_to_develop_lupus_therasight_091015-2/</loc>
		<lastmod>2009-10-15T10:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_receives_approval_for_cervarix_in_japan_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adiposederived_stem_regenerative_cells_show_positive_results_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_astrazenecas_crestor_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quidel_reports_net_income_of_149_million_in_q3_2009_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto_issues_patent_to_alios_for_glycoengineered_interferons_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_pozen_submit_maa_in_eu_for_vimovo_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_receives_fda_approval_for_cervarix_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quidel_reports_increase_in_q3_total_revenue_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_releases_results_from_second_clinical_trial_of_h1n1_vaccine_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_aventis_gets_marketing_approval_for_elitek_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iavi_to_partner_with_ragon_institute_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer_therapeutics_to_increase_stake_to_51_in_nano_therapies_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/toray_obtains_approval_to_add_new_indication_to_feron_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/generex_launches_generex_orallyn_in_algeria_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva_comments_on_mylan_paragraph_iv_filing_for_copaxone_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_combines_operations_with_wyeth_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access_releases_update_on_mugard_commercial_launch_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mhlw_approves_symbicort_turbuhaler_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/targacept_releases_data_from_phase_2b_trial_for_tc5214_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinical_center_of_serbia_treats_first_patient_in_ccure_trial_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharming_q3_income_increases_091016-2/</loc>
		<lastmod>2009-10-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech_biogen_receive_complete_response_from_fda_for_rituxan_091017-2/</loc>
		<lastmod>2009-10-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucbs_cimzia_shows_sustained_clinical_response_091017-2/</loc>
		<lastmod>2009-10-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest_laboratories_cypress_report_improvements_in_pain_physical_function_by_savella_091017-2/</loc>
		<lastmod>2009-10-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actemra_inhibits_progression_of_rheumatoid_arthritis_091017-2/</loc>
		<lastmod>2009-10-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uloric_demonstrates_ability_to_manage_hyperuricemia_in_gout_patients_091017-2/</loc>
		<lastmod>2009-10-16T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hig_capital_to_acquire_allion_healthcare_091018-2/</loc>
		<lastmod>2009-10-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/angiochem_reports_positive_results_for_ang1005_091018-2/</loc>
		<lastmod>2009-10-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medidata_solutions_extends_contract_with_bristolmyers_squibb_091019-2/</loc>
		<lastmod>2009-10-18T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_gets_approval_for_basen_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_receives_complete_response_letter_from_fda_for_qab149_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen_idec_biovitrum_plan_to_advance_rfixfc_into_registrational_trial_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mmv_obtains_115m_grant_from_gates_foundation_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viriom_selects_chemdiv_to_develop_hiv_program_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chempartner_to_foray_into_europe_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xenoport_initiates_phase_2b_trial_for_arbaclofen_placarbil_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qlt_restructures_visudyne_agreement_with_novartis_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hgs_earns_75m_milestone_payment_from_novartis_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnara_releases_results_from_phase_3_study_for_liprotamase_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/talecriss_prolastinc_gets_fda_approval_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quotient_receives_fda_approval_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tracon_enters_into_rd_agreement_with_nci_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rexahn_reports_positive_topline_phase_iia_results_for_serdaxin_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celsions_expands_phase_iii_thermodox_trial_to_malaysia_philippines_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo_fisher_scientific_to_invest_89_million_to_expand_in_middletown_in_frederick_county_creating_50_jobs_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_issues_complete_response_letter_to_amgen_for_its_bla_for_prolia_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsks_votrient_receives_fda_approval_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biobridge_science_receives_business_license_for_biobridge_jrs_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_launches_clikstar_in_canada_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mwv_receives_chainofcustody_certifications_for_two_packaging_facilities_in_europe_091019-2/</loc>
		<lastmod>2009-10-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/velocity_medical_solutions_launches_new_subscription_service_091019-2/</loc>
		<lastmod>2009-10-19T04:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ldn_research_trust_suggests_ldn_for_ms_091019-2/</loc>
		<lastmod>2009-10-19T09:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european_sexual_confidence_survey_releases_findings_on_ed_091019-2/</loc>
		<lastmod>2009-10-19T09:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icagen_reports_progress_in_identifying_selective_sodium_channel_inhibitors_091019-2/</loc>
		<lastmod>2009-10-19T09:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emisphere_declares_results_for_pth134_091020-2/</loc>
		<lastmod>2009-10-19T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/apt_files_patent_application_on_slmt_091020-2/</loc>
		<lastmod>2009-10-19T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_introduces_zoneperfect_indulgence_nutrition_squares_091019-2/</loc>
		<lastmod>2009-10-19T14:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/siro_clinpharm_expands_facility_in_mumbai_india_091019-2/</loc>
		<lastmod>2009-10-19T14:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avx_cabot_announce_litigation_settlement_091019-2/</loc>
		<lastmod>2009-10-19T14:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hydra_biosciences_cubist_form_collaboration_091019-2/</loc>
		<lastmod>2009-10-19T15:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan_resolves_longstanding_dispute_regarding_certain_medicaid_rebate_classifications_from_2000_through_2004_091019-2/</loc>
		<lastmod>2009-10-19T15:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hgs_gsk_release_positive_phase_3_study_results_for_belimumab_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartiss_tasigna_meets_primary_endpoint_in_pivotal_trial_against_glivec_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_acz885_found_to_be_more_effective_than_corticosteroid_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/morphosys_seals_agreement_with_daiichi_sankyo_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/menarini_receives_exclusive_licence_rights_for_adenuric_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/affiris_unveil_results_for_phase_i_alzheimers_trial_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/beneo_palatinit_introduces_galeniq_981_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_grants_510k_clearance_to_abbott_for_cycliccitrulinated_peptide_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto_issues_patent_to_prometheus_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/technovax_obtains_29m_grant_from_nih_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_acquires_visiogen_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dsp_completes_acquisition_of_sepracor_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_reports_dip_in_q3_revenues_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmaco_group_starts_production_of_new_medicines_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_enrolls_first_patient_in_phase_3_trail_of_genz112638_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xoma_presents_xoma_052_cardiovascular_disease_animal_model_results_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mediwounds_debrase_reports_positive_results_in_phase_iii_trail_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novavax_initiates_study_for_vlp_h1n1_influenza_vaccine_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristolmyers_squibb_reports_positive_results_for_orencia_trial_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/freeman_technology_harro_hofliger_to_launch_freeman_technology_ft4_powder_rheometer_091020-2/</loc>
		<lastmod>2009-10-19T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/almirall_provides_update_on_eklira_for_copd_091020-2/</loc>
		<lastmod>2009-10-20T10:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actelion_posts_net_revenues_of_chf13025m_091020-2/</loc>
		<lastmod>2009-10-20T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kinaxo_enters_into_agreement_with_roche_091021-2/</loc>
		<lastmod>2009-10-20T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protein_discovery_signs_agreement_with_new_objective_091021-2/</loc>
		<lastmod>2009-10-20T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biostorage_opens_new_german_facility_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ista_releases_bepreve_clinical_data_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wellstat_seals_agreement_with_sanofiaventis_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinobiopharma_revenue_increases_by_39_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/app_obtains_fda_approval_for_chlorothiazide_sodium_for_injection_usp_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lonza_enters_into_agreement_with_alnara_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/smc_approves_tibotecs_prezista_for_use_in_nhs_scotland_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nice_rejects_tyverb_in_combination_with_capecitabine_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novavax_partners_with_xcellerex_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/molecular_insight_executes_onalta_manufacturing_supply_agreements_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/macusight_receives_fast_track_designation_from_fda_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/laureate_signs_new_biopharmaceutical_development_manufacturing_agreement_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cdc_advisory_committee_recommends_gsks_cervarix_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kaiser_permanentes_first_clinical_trial_to_help_obese_women_maintain_weight_during_pregnancy_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/verichip_seals_partnership_with_dri_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine_reports_positive_results_from_phase_ii_trial_for_bavituximab_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/endocyte_releases_data_on_ec145_for_treatment_of_ovarian_cancer_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/entest_biomedical_seeks_to_acquire_therinject_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/persistent_purchases_meadwestvacos_paxonix_business_091021-2/</loc>
		<lastmod>2009-10-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ge_lilly_report_positive_advancement_in_cancer_research_091021-2/</loc>
		<lastmod>2009-10-21T07:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/optigenex_enters_into_supply_license_agreement_with_suracell_091021-2/</loc>
		<lastmod>2009-10-21T08:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genprobe_files_patent_lawsuit_against_bd_091021-2/</loc>
		<lastmod>2009-10-21T12:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vanderbilt_university_receives_100000_grand_challenges_explorations_grant_for_coffee_ring_stain_diagnostics_for_malaria_091021-2/</loc>
		<lastmod>2009-10-21T12:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/halozyme_roche_initiate_phase_3_trial_for_herceptin_091022-2/</loc>
		<lastmod>2009-10-21T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zygem_enters_into_agreement_with_phthisis_091022-2/</loc>
		<lastmod>2009-10-21T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb_reports_promising_early_results_for_new_products_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_reports_rise_in_q3_net_income_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec_obtains_e25m_milestone_payment_from_boehringer_ingelheim_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sosei_provides_update_on_nva237_qva149_studies_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipierian_to_collaborate_with_johns_hopkins_university_on_37m_nih_grant_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pacificgmp_to_manufacture_fusion_protein_for_armagen_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aerie_reports_positive_results_in_phase_2a_study_for_ar12286_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinus_dynamics_introduces_nasallyinhaled_aerosolized_form_of_vancomycin_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/response_biomedical_gets_fda_clearance_for_update_to_ramp_influenza_ab_assay_package_insert_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zogenix_astellas_report_positive_clinical_results_for_new_needlefree_delivery_system_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emd_seals_collaboration_with_mitosciences_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medimmune_reports_interim_results_for_laiv_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/manipal_cure_and_care_launches_hand_sanitizer_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac_gets_approval_to_distribute_panflu1_in_mexico_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aethlon_establishes_exosome_sciences_a_new_subsidiary_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_china_installs_sephas_blisterscan_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_reports_increase_in_worldwide_sales_for_q3_2009_091022-2/</loc>
		<lastmod>2009-10-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fuji_health_science_extends_excipient_technology_091022-2/</loc>
		<lastmod>2009-10-22T07:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/blood_bank_of_alaska_opts_mediwares_lifetrak_technology_091023-2/</loc>
		<lastmod>2009-10-22T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european_commission_grants_marketing_authorisation_for_novartis_exforge_hct_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_onyx_initiate_patient_enrollment_in_phase_iii_trial_for_nexavar_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emea_issues_positive_opinion_for_micardis_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_launches_new_rd_facility_at_university_of_illinois_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medgenics_signs_agreement_with_international_pharma_major_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_scheringplough_obtain_ec_approval_for_merger_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cohera_obtains_approval_to_initiate_human_clinical_trials_for_tissuglu_in_germany_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/potentia_seals_licensing_purchase_option_agreements_with_alcon_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lonza_acquires_stake_in_cilian_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mpi_research_to_sign_collaboration_with_kineta_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aldevron_expands_in_madison_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allergan_wins_brimonidine_patent_infringement_case_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xeta_bags_3year_contract_from_siemens_enterprise_network_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomoda_enters_final_stage_of_patient_testing_for_phase_ii_lung_cancer_clinical_study_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp_grants_positive_opinion_for_angiox_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_grants_emergency_use_authorisation_to_peramivir_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/exelixis_bristolmyers_squibb_reports_phase_2_data_for_brain_cancer_trial_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/camfil_bags_contract_to_work_with_pfizer_091023-2/</loc>
		<lastmod>2009-10-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gea_niro_extends_to_cgmp_contract_spray_drying_091023-2/</loc>
		<lastmod>2009-10-23T04:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hovione_completes_acquisition_of_aseptic_spraydrying_production_line_091023-2/</loc>
		<lastmod>2009-10-23T14:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orexigen_presents_new_data_showing_weight_loss_with_contrave_091024-2/</loc>
		<lastmod>2009-10-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arena_pharmaceuticals_reports_positive_data_for_bloom_trial_091025-2/</loc>
		<lastmod>2009-10-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/impax_starts_second_phase_iii_trial_for_ipx066_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quark_expands_patent_protection_for_compounds_targeting_rtp801_gene_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer_ingelheim_closes_deal_with_pfizer_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stellar_seals_licensing_agreement_with_jeilmedix_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epicept_to_release_new_findings_for_ceplene_drug_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/apogee_technology_presents_data_on_intradermal_immunization_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_inks_deal_with_minsheng_pharmaceutical_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/siemens_collaborates_with_efpia_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_affirms_fiveyear_grant_to_shires_vyvanse_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elron_receives_nonbinding_indication_of_interest_to_acquire_medingo_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genesilencing_protein_offers_new_possibilities_for_treatment_of_cancer_genetic_disorders_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/second_partner_to_negotiate_licensing_terms_for_cerashield_antimicrobial_coating_application_091026-2/</loc>
		<lastmod>2009-10-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ingenuity_systems_enhances_workflow_for_experimental_transcriptome_analysis_in_single_cells_091026-2/</loc>
		<lastmod>2009-10-25T23:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iris_international_reports_initiation_of_pivotal_retrospective_clinical_study_using_nadia_prosvue_091026-2/</loc>
		<lastmod>2009-10-26T04:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/potentia_pharmaceuticals_enters_into_licensing_purchase_option_agreements_with_alcon_091026-2/</loc>
		<lastmod>2009-10-26T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biocon_reports_profits_of_inr74_crore_091026-2/</loc>
		<lastmod>2009-10-26T05:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ranbaxy_records_consistent_improvement_in_operating_performance_091026-2/</loc>
		<lastmod>2009-10-26T06:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_revenues_increase_by_27_to_e19_billion_091026-2/</loc>
		<lastmod>2009-10-26T06:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmalink_obtains_japanese_patent_for_nefecon_091026-2/</loc>
		<lastmod>2009-10-26T07:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto_reaffirms_validity_of_splicearray_patent_091026-2/</loc>
		<lastmod>2009-10-26T10:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/horizon_presents_phase_3_study_results_for_indentifying_risk_factors_for_ulcer_development_091026-2/</loc>
		<lastmod>2009-10-26T11:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nps_pharmaceuticals_reports_data_for_phase_3_study_supporting_gattex_091026-2/</loc>
		<lastmod>2009-10-26T12:22:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ebioscience_takes_over_bender_medsystems_091027-2/</loc>
		<lastmod>2009-10-26T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genenews_enters_into_agreement_with_eli_lilly_091027-2/</loc>
		<lastmod>2009-10-26T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/supergen_gsk_to_collaborate_on_discovery_development_of_new_epigenetic_therapeutics_091026-2/</loc>
		<lastmod>2009-10-26T13:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/promoted_summit_puts_medication_management_under_microscope_091026-2/</loc>
		<lastmod>2009-10-26T13:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/solvay_posts_new_data_for_creon_091026-2/</loc>
		<lastmod>2009-10-26T13:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genmab_reaches_milestone_for_arzerra_in_gsk_collaboration_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icagen_unveils_results_of_phase_iia_study_for_senicapoc_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_genmab_obtains_accelerated_approval_for_arzerra_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomarin_takes_over_huxley_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_allows_use_of_12_new_structural_health_claims_filed_for_astaxanthin_in_the_us_market_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/university_of_southampton_receives_grant_from_bill__melinda_gates_foundation_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scynexis_obtains_milestone_payment_in_collaboration_with_merck_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmaceutical_business_review_launches_major_pharma_survey_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac_bags_third_h1n1_vaccine_order_from_china_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas_medivation_enter_into_worldwide_agreement_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alkermes_initiates_phase_1_clinical_study_of_alks_37_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/king_pharmaceuticals_licenses_rights_to_cyanokit_in_us_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/champions_seals_exclusive_licensing_agreement_with_ramot_for_tar1_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto_issues_patent_to_endocyte_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/romaco_presents_siebler_hm_1230_at_pmec_2009_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_provides_update_on_pandemic_2009_influenza_vaccine_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regenerons_rilonacept_gets_eu_marketing_authorisation_for_rilonacept_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/polymedix_concludes_phase_1b_study_of_heparin_antagonist_pmx600_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sequenom_settles_patent_infringement_suit_with_ibis_biosciences_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/microbix_forms_joint_venture_with_hunan_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_withdraws_notice_of_eligibility_request_for_safety_effectiveness_data_regarding_s_boulardii_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/indus_obtains_fda_approval_for_aids_molecule_trials_091027-2/</loc>
		<lastmod>2009-10-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boston_medical_center_selects_fusionfx_immunization_management_portal_091027-2/</loc>
		<lastmod>2009-10-27T09:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zymogenetics_bristolmyers_squibb_initiates_phase_2_clinical_trial_for_peginterferon_lambda_091027-2/</loc>
		<lastmod>2009-10-27T11:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mnx_nominates_gtx_corp_to_provide_secure_2way_gps_realtime_tracking_of_medical_biopharmaceutical_shipments_091027-2/</loc>
		<lastmod>2009-10-27T12:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/praxis_emr_offers_new_version_with_ehr_documentation_091028-2/</loc>
		<lastmod>2009-10-27T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/unilife_to_market_readytofill_syringes_under_unifill_brand_091027-2/</loc>
		<lastmod>2009-10-27T14:03:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomerica_plans_for_new_headquarters_in_irvine_california_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/smiths_medical_gets_us_government_order_for_safety_hypodermic_syringes_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ncku_seals_technology_transfer_agreement_with_vedan_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_ilaris_gets_approval_in_eu_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thrombogenics_bioinvent_conclude_patient_enrollment_in_phase_ii_study_for_tb402_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_withdraws_regulatory_submissions_for_zactima_in_combination_with_chemotherapy_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire_receives_european_wide_label_extension_for_fosrenol_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nektar_concludes_enrollment_in_phase_2_clinical_trial_for_nktr102_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai_tsd_japan_seal_license_development_agreement_for_denileukin_diftitox_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/excelimmune_receives_sbir_grant_from_nih_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uspto_issues_fundamental_microrna_therapeutics_patent_to_regulus_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novavax_cpl_biologicals_launch_new_manufacturing_facility_in_india_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/desitin_files_for_european_regulatory_approval_for_sumavel_dosepro_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advaxis_gets_irb_approval_for_phase_ii_trial_of_adxs11001_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_court_rejects_litigation_against_nutrisystem_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas_submits_maa_to_emea_for_telavancin_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cyclacel_reports_survival_data_from_phase_2_sapacitabine_study_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/midway_importing_to_distribute_banner_pharmacaps_gelcaps_in_us_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ekr_receives_usptos_notice_of_patent_allowance_for_rtu_cardene_iv_bags_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/socma_receives_fdas_response_to_citizen_petition_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_reports_15_increase_in_q3_revenue_091028-2/</loc>
		<lastmod>2009-10-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_selects_qms_solution_from_mastercontrol_i4dm_091029-2/</loc>
		<lastmod>2009-10-28T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/map_completes_interim_safety_review_of_levadex_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/swine_flu_increases_otc_medicine_sales_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/interleukin_genetics_enters_partnership_agreement_with_amway_global_to_sell_inherent_health_brand_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bikam_dalton_renew_expand_research_agreement_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire_reports_new_data_from_intuniv_study_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cumberland_phebra_seal_agreement_to_commercialise_caldolor_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_releases_results_of_first_phase_iii_study_for_taspoglutide_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen_launches_dysport_in_us_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_delivers_influenza_a_vaccine_to_us_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transcept_receives_fdas_complete_response_letter_for_intermezzo_nda_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/simcere_to_acquire_7449_stake_in_chinavax_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/octapharma_seals_license_development_supply_agreement_with_fresenius_kabi_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi_sankyo_submits_application_for_approval_of_levofloxacin_hydrate_injection_in_japan_091029-2/</loc>
		<lastmod>2009-10-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ccbrsynarc_enhances_its_electronic_data_capture_capabilities_091030-2/</loc>
		<lastmod>2009-10-29T13:00:00+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->